Are you a new member? Sign up now
Login area
| Sign up
close
DUPIXENT - 300mg - 2
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D11AH05 | BioTech | Dupilumab - 300mg | 11809 | 1324/1 | DUPIXENT | 300mg | 2 | Injectable solution | SC | Mersaco | Sanofi Winthrop Industrie | France | 123,001,362 L.L | 2.44 | E2 | Sanofi Winthrop Industrie | France | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D11AH05 | BioTech | Dupilumab - 300mg | 10255 | 163219/1 | DUPIXENT | 300mg | 2 | Injectable solution | SC | Mersaco | Sanofi Winthrop Industrie | France | 123,001,362 L.L | 2.44 | E2 | Sanofi Aventis Groupe | France | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024